Calamos Growth and Income Portfolio Buys Abbott Laboratories, Huntington Bancshares Inc, Eli Lilly and Co, Sells Baxter International Inc, Humana Inc, Global Payments Inc

Investment company Calamos Growth and Income Portfolio (Current Portfolio) buys Abbott Laboratories, Huntington Bancshares Inc, Eli Lilly and Co, sells Baxter International Inc, Humana Inc, Global Payments Inc, Micron Technology Inc, Tesla Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Calamos Growth and Income Portfolio. As of 2021Q3, Calamos Growth and Income Portfolio owns 104 stocks with a total value of $25 million. These are the details of the buys and sells.

For the details of Calamos Growth and Income Portfolio's stock buys and sells, go to https://www.gurufocus.com/guru/calamos+growth+and+income+portfolio/current-portfolio/portfolio

These are the top 5 holdings of Calamos Growth and Income Portfolio
  1. Microsoft Corp (MSFT) - 6,215 shares, 7.03% of the total portfolio. Shares reduced by 2.74%
  2. Apple Inc (AAPL) - 12,215 shares, 6.94% of the total portfolio. Shares reduced by 5.46%
  3. Alphabet Inc (GOOGL) - 500 shares, 5.37% of the total portfolio. Shares reduced by 2.91%
  4. Amazon.com Inc (AMZN) - 355 shares, 4.68% of the total portfolio. Shares reduced by 4.05%
  5. Meta Platforms Inc (FB) - 2,015 shares, 2.74% of the total portfolio.
New Purchase: Huntington Bancshares Inc (HBAN)

Calamos Growth and Income Portfolio initiated holding in Huntington Bancshares Inc. The purchase prices were between $13.23 and $15.8, with an estimated average price of $14.72. The stock is now traded at around $14.920000. The impact to a portfolio due to this purchase was 0.15%. The holding were 2,375 shares as of 2021-09-30.

Added: Abbott Laboratories (ABT)

Calamos Growth and Income Portfolio added to a holding in Abbott Laboratories by 100.00%. The purchase prices were between $116.66 and $129.06, with an estimated average price of $122.86. The stock is now traded at around $135.930000. The impact to a portfolio due to this purchase was 0.39%. The holding were 1,630 shares as of 2021-09-30.

Added: Eli Lilly and Co (LLY)

Calamos Growth and Income Portfolio added to a holding in Eli Lilly and Co by 39.13%. The purchase prices were between $221.6 and $272.71, with an estimated average price of $246.81. The stock is now traded at around $248.650000. The impact to a portfolio due to this purchase was 0.13%. The holding were 480 shares as of 2021-09-30.

Sold Out: Baxter International Inc (BAX)

Calamos Growth and Income Portfolio sold out a holding in Baxter International Inc. The sale prices were between $73.77 and $83.61, with an estimated average price of $79.12.

Sold Out: Humana Inc (HUM)

Calamos Growth and Income Portfolio sold out a holding in Humana Inc. The sale prices were between $389.15 and $471.22, with an estimated average price of $424.73.

Sold Out: Global Payments Inc (GPN)

Calamos Growth and Income Portfolio sold out a holding in Global Payments Inc. The sale prices were between $156.58 and $195.16, with an estimated average price of $173.79.



Here is the complete portfolio of Calamos Growth and Income Portfolio. Also check out:

1. Calamos Growth and Income Portfolio's Undervalued Stocks
2. Calamos Growth and Income Portfolio's Top Growth Companies, and
3. Calamos Growth and Income Portfolio's High Yield stocks
4. Stocks that Calamos Growth and Income Portfolio keeps buying